Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-10-25

Clinical Trial Update: DHEA Supplementation for Low Ovarian Response IVF Patients [NA]

View source ↗

Summary

The update concerns dehydroepiandrosterone (DHEA) supplementation to improve ovarian response in women undergoing IVF, with the trial status currently listed as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DHEA (dehydroepiandrosterone)

Snippet

Sponsor: Shaare Zedek Medical Center | Conditions: Infertility, Female, In-Vitro Fertilization | NA | Status: UNKNOWN